Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
Identifieur interne : 002550 ( Main/Exploration ); précédent : 002549; suivant : 002551Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
Auteurs : Baojing Lu [République populaire de Chine] ; Yi Huang ; Li Huang ; Bao Li [République populaire de Chine] ; Zhenhua Zheng ; Ze Chen ; Jianjun Chen ; Qinxue Hu ; Hanzhong WangSource :
- Immunology [ 0019-2805 ] ; 2010.
Descripteurs français
- KwdFr :
- Adjuvants immunologiques (pharmacologie), Animaux, Anticorps antiviraux (immunologie), Anticorps antiviraux (sang), Anticorps neutralisants (immunologie), Anticorps neutralisants (sang), Baculoviridae, Femelle, Immunisation (), Immunité muqueuse (), Immunité muqueuse (immunologie), Immunoglobuline A (immunologie), Immunoglobuline A (sang), Immunoglobuline G (immunologie), Immunoglobuline G (sang), Modèles animaux de maladie humaine, Oligodésoxyribonucléotides (pharmacocinétique), Souris, Souris de lignée BALB C, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (sang), Vaccins antiviraux (génétique), Vaccins antiviraux (immunologie), Vaccins antiviraux (pharmacocinétique), Virus du SRAS (génétique), Virus du SRAS (immunologie).
- MESH :
- génétique : Vaccins antiviraux, Virus du SRAS.
- immunologie : Anticorps antiviraux, Anticorps neutralisants, Immunité muqueuse, Immunoglobuline A, Immunoglobuline G, Syndrome respiratoire aigu sévère, Vaccins antiviraux, Virus du SRAS.
- pharmacocinétique : Oligodésoxyribonucléotides, Vaccins antiviraux.
- pharmacologie : Adjuvants immunologiques.
- sang : Anticorps antiviraux, Anticorps neutralisants, Immunoglobuline A, Immunoglobuline G, Syndrome respiratoire aigu sévère.
- Animaux, Baculoviridae, Femelle, Immunisation, Immunité muqueuse, Modèles animaux de maladie humaine, Souris, Souris de lignée BALB C, Syndrome respiratoire aigu sévère.
English descriptors
- KwdEn :
- Adjuvants, Immunologic (pharmacology), Animals, Antibodies, Neutralizing (blood), Antibodies, Neutralizing (immunology), Antibodies, Viral (blood), Antibodies, Viral (immunology), Baculoviridae, Disease Models, Animal, Female, Immunity, Mucosal (drug effects), Immunity, Mucosal (immunology), Immunization (methods), Immunoglobulin A (blood), Immunoglobulin A (immunology), Immunoglobulin G (blood), Immunoglobulin G (immunology), Mice, Mice, Inbred BALB C, Oligodeoxyribonucleotides (pharmacokinetics), SARS Virus (genetics), SARS Virus (immunology), Severe Acute Respiratory Syndrome (blood), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (prevention & control), Viral Vaccines (genetics), Viral Vaccines (immunology), Viral Vaccines (pharmacokinetics).
- MESH :
- chemical , blood : Antibodies, Neutralizing, Antibodies, Viral, Immunoglobulin A, Immunoglobulin G.
- chemical , genetics : Viral Vaccines.
- chemical , immunology : Antibodies, Neutralizing, Antibodies, Viral, Immunoglobulin A, Immunoglobulin G, Viral Vaccines.
- chemical , pharmacokinetics : Oligodeoxyribonucleotides, Viral Vaccines.
- chemical , pharmacology : Adjuvants, Immunologic.
- blood : Severe Acute Respiratory Syndrome.
- drug effects : Immunity, Mucosal.
- genetics : SARS Virus.
- immunology : Immunity, Mucosal, SARS Virus, Severe Acute Respiratory Syndrome.
- methods : Immunization.
- prevention & control : Severe Acute Respiratory Syndrome.
- Animals, Baculoviridae, Disease Models, Animal, Female, Mice, Mice, Inbred BALB C.
Abstract
Nasal administration has emerged as a promising and attractive route for vaccination, especially for the prophylaxis of respiratory diseases. Our previous studies have shown that severe acute respiratory syndrome coronavirus (SARS-CoV) virus-like particles (VLPs) can be assembled using a recombinant baculovirus (rBV) expression system and such VLPs induce specific humoral and cellular immune responses in mice after subcutaneous injection. Here, we investigated mucosal immune responses to SARS-CoV VLPs in a mouse model. Mice were immunized in parallel, intraperitoneally or intranasally, with VLPs alone or with VLPs plus cytosine–phosphate–guanosine (CpG). Immune responses, including the production of SARS-CoV-specific serum immunoglobulin G (IgG) and secretory immunoglobulin A (sIgA), were determined in mucosal secretions and tissues. Both immunizations induced SARS-CoV-specific IgG, although the levels of IgG in groups immunized via the intraperitoneal (i.p.) route were higher. sIgA was detected in saliva in groups immunized intranasally but not in groups immunized intraperitoneally. CpG had an adjuvant effect on IgA production in genital tract washes when administered intranasally but only affected IgA production in faeces samples when administered intraperitoneally. In addition, IgA was also detected in mucosal tissues from the lung and intestine, while CpG induced an increased level of IgA in the intestine. Most importantly, neutralization antibodies were detected in sera after i.p. and intranasal (i.n.) immunizations. Secretions in genital tract washes from the i.n. group also showed neutralization activity. Furthermore, VLPs that were administered intraperitoneally elicited cellular immune responses as demonstrated by enzyme-linked immunospot (ELISPOT) assay analyses. In summary, our study indicates that mucosal immunization with rBV SARS-CoV VLPs represent an effective means for eliciting protective systemic and mucosal immune responses against SARS-CoV, providing important information for vaccine design.
Url:
DOI: 10.1111/j.1365-2567.2010.03231.x
PubMed: 20406307
PubMed Central: 2878469
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000C53
- to stream Pmc, to step Curation: 000C53
- to stream Pmc, to step Checkpoint: 000C35
- to stream PubMed, to step Corpus: 001716
- to stream PubMed, to step Curation: 001716
- to stream PubMed, to step Checkpoint: 001685
- to stream Ncbi, to step Merge: 002124
- to stream Ncbi, to step Curation: 002124
- to stream Ncbi, to step Checkpoint: 002124
- to stream Main, to step Merge: 002587
- to stream Main, to step Curation: 002550
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice</title><author><name sortKey="Lu, Baojing" sort="Lu, Baojing" uniqKey="Lu B" first="Baojing" last="Lu">Baojing Lu</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation><affiliation wicri:level="1"><nlm:aff id="au2"><institution>Anhui Medical University</institution><addr-line>Hefei, China</addr-line></nlm:aff><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Hefei</wicri:regionArea></affiliation></author><author><name sortKey="Huang, Yi" sort="Huang, Yi" uniqKey="Huang Y" first="Yi" last="Huang">Yi Huang</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Huang, Li" sort="Huang, Li" uniqKey="Huang L" first="Li" last="Huang">Li Huang</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Li, Bao" sort="Li, Bao" uniqKey="Li B" first="Bao" last="Li">Bao Li</name><affiliation wicri:level="1"><nlm:aff id="au2"><institution>Anhui Medical University</institution><addr-line>Hefei, China</addr-line></nlm:aff><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Hefei</wicri:regionArea></affiliation></author><author><name sortKey="Zheng, Zhenhua" sort="Zheng, Zhenhua" uniqKey="Zheng Z" first="Zhenhua" last="Zheng">Zhenhua Zheng</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chen, Ze" sort="Chen, Ze" uniqKey="Chen Z" first="Ze" last="Chen">Ze Chen</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chen, Jianjun" sort="Chen, Jianjun" uniqKey="Chen J" first="Jianjun" last="Chen">Jianjun Chen</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hu, Qinxue" sort="Hu, Qinxue" uniqKey="Hu Q" first="Qinxue" last="Hu">Qinxue Hu</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Wang, Hanzhong" sort="Wang, Hanzhong" uniqKey="Wang H" first="Hanzhong" last="Wang">Hanzhong Wang</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">20406307</idno><idno type="pmc">2878469</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878469</idno><idno type="RBID">PMC:2878469</idno><idno type="doi">10.1111/j.1365-2567.2010.03231.x</idno><date when="2010">2010</date><idno type="wicri:Area/Pmc/Corpus">000C53</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000C53</idno><idno type="wicri:Area/Pmc/Curation">000C53</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000C53</idno><idno type="wicri:Area/Pmc/Checkpoint">000C35</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000C35</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:20406307</idno><idno type="wicri:Area/PubMed/Corpus">001716</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001716</idno><idno type="wicri:Area/PubMed/Curation">001716</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001716</idno><idno type="wicri:Area/PubMed/Checkpoint">001685</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001685</idno><idno type="wicri:Area/Ncbi/Merge">002124</idno><idno type="wicri:Area/Ncbi/Curation">002124</idno><idno type="wicri:Area/Ncbi/Checkpoint">002124</idno><idno type="wicri:doubleKey">0019-2805:2010:Lu B:effect:of:mucosal</idno><idno type="wicri:Area/Main/Merge">002587</idno><idno type="wicri:Area/Main/Curation">002550</idno><idno type="wicri:Area/Main/Exploration">002550</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice</title><author><name sortKey="Lu, Baojing" sort="Lu, Baojing" uniqKey="Lu B" first="Baojing" last="Lu">Baojing Lu</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation><affiliation wicri:level="1"><nlm:aff id="au2"><institution>Anhui Medical University</institution><addr-line>Hefei, China</addr-line></nlm:aff><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Hefei</wicri:regionArea></affiliation></author><author><name sortKey="Huang, Yi" sort="Huang, Yi" uniqKey="Huang Y" first="Yi" last="Huang">Yi Huang</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Huang, Li" sort="Huang, Li" uniqKey="Huang L" first="Li" last="Huang">Li Huang</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Li, Bao" sort="Li, Bao" uniqKey="Li B" first="Bao" last="Li">Bao Li</name><affiliation wicri:level="1"><nlm:aff id="au2"><institution>Anhui Medical University</institution><addr-line>Hefei, China</addr-line></nlm:aff><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Hefei</wicri:regionArea></affiliation></author><author><name sortKey="Zheng, Zhenhua" sort="Zheng, Zhenhua" uniqKey="Zheng Z" first="Zhenhua" last="Zheng">Zhenhua Zheng</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chen, Ze" sort="Chen, Ze" uniqKey="Chen Z" first="Ze" last="Chen">Ze Chen</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Chen, Jianjun" sort="Chen, Jianjun" uniqKey="Chen J" first="Jianjun" last="Chen">Jianjun Chen</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hu, Qinxue" sort="Hu, Qinxue" uniqKey="Hu Q" first="Qinxue" last="Hu">Qinxue Hu</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author><author><name sortKey="Wang, Hanzhong" sort="Wang, Hanzhong" uniqKey="Wang H" first="Hanzhong" last="Wang">Hanzhong Wang</name><affiliation><nlm:aff id="au1"><institution>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science</institution><addr-line>Wuhan</addr-line></nlm:aff></affiliation></author></analytic><series><title level="j">Immunology</title><idno type="ISSN">0019-2805</idno><idno type="eISSN">1365-2567</idno><imprint><date when="2010">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (pharmacology)</term><term>Animals</term><term>Antibodies, Neutralizing (blood)</term><term>Antibodies, Neutralizing (immunology)</term><term>Antibodies, Viral (blood)</term><term>Antibodies, Viral (immunology)</term><term>Baculoviridae</term><term>Disease Models, Animal</term><term>Female</term><term>Immunity, Mucosal (drug effects)</term><term>Immunity, Mucosal (immunology)</term><term>Immunization (methods)</term><term>Immunoglobulin A (blood)</term><term>Immunoglobulin A (immunology)</term><term>Immunoglobulin G (blood)</term><term>Immunoglobulin G (immunology)</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Oligodeoxyribonucleotides (pharmacokinetics)</term><term>SARS Virus (genetics)</term><term>SARS Virus (immunology)</term><term>Severe Acute Respiratory Syndrome (blood)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>Viral Vaccines (genetics)</term><term>Viral Vaccines (immunology)</term><term>Viral Vaccines (pharmacokinetics)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants immunologiques (pharmacologie)</term><term>Animaux</term><term>Anticorps antiviraux (immunologie)</term><term>Anticorps antiviraux (sang)</term><term>Anticorps neutralisants (immunologie)</term><term>Anticorps neutralisants (sang)</term><term>Baculoviridae</term><term>Femelle</term><term>Immunisation ()</term><term>Immunité muqueuse ()</term><term>Immunité muqueuse (immunologie)</term><term>Immunoglobuline A (immunologie)</term><term>Immunoglobuline A (sang)</term><term>Immunoglobuline G (immunologie)</term><term>Immunoglobuline G (sang)</term><term>Modèles animaux de maladie humaine</term><term>Oligodésoxyribonucléotides (pharmacocinétique)</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Syndrome respiratoire aigu sévère ()</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (sang)</term><term>Vaccins antiviraux (génétique)</term><term>Vaccins antiviraux (immunologie)</term><term>Vaccins antiviraux (pharmacocinétique)</term><term>Virus du SRAS (génétique)</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Neutralizing</term><term>Antibodies, Viral</term><term>Immunoglobulin A</term><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Neutralizing</term><term>Antibodies, Viral</term><term>Immunoglobulin A</term><term>Immunoglobulin G</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Oligodeoxyribonucleotides</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Adjuvants, Immunologic</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Immunity, Mucosal</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Vaccins antiviraux</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term><term>Anticorps neutralisants</term><term>Immunité muqueuse</term><term>Immunoglobuline A</term><term>Immunoglobuline G</term><term>Syndrome respiratoire aigu sévère</term><term>Vaccins antiviraux</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Immunity, Mucosal</term><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Immunization</term></keywords><keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Oligodésoxyribonucléotides</term><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Adjuvants immunologiques</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term><term>Anticorps neutralisants</term><term>Immunoglobuline A</term><term>Immunoglobuline G</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Baculoviridae</term><term>Disease Models, Animal</term><term>Female</term><term>Mice</term><term>Mice, Inbred BALB C</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Baculoviridae</term><term>Femelle</term><term>Immunisation</term><term>Immunité muqueuse</term><term>Modèles animaux de maladie humaine</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Syndrome respiratoire aigu sévère</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Nasal administration has emerged as a promising and attractive route for vaccination, especially for the prophylaxis of respiratory diseases. Our previous studies have shown that severe acute respiratory syndrome coronavirus (SARS-CoV) virus-like particles (VLPs) can be assembled using a recombinant baculovirus (rBV) expression system and such VLPs induce specific humoral and cellular immune responses in mice after subcutaneous injection. Here, we investigated mucosal immune responses to SARS-CoV VLPs in a mouse model. Mice were immunized in parallel, intraperitoneally or intranasally, with VLPs alone or with VLPs plus cytosine–phosphate–guanosine (CpG). Immune responses, including the production of SARS-CoV-specific serum immunoglobulin G (IgG) and secretory immunoglobulin A (sIgA), were determined in mucosal secretions and tissues. Both immunizations induced SARS-CoV-specific IgG, although the levels of IgG in groups immunized via the intraperitoneal (i.p.) route were higher. sIgA was detected in saliva in groups immunized intranasally but not in groups immunized intraperitoneally. CpG had an adjuvant effect on IgA production in genital tract washes when administered intranasally but only affected IgA production in faeces samples when administered intraperitoneally. In addition, IgA was also detected in mucosal tissues from the lung and intestine, while CpG induced an increased level of IgA in the intestine. Most importantly, neutralization antibodies were detected in sera after i.p. and intranasal (i.n.) immunizations. Secretions in genital tract washes from the i.n. group also showed neutralization activity. Furthermore, VLPs that were administered intraperitoneally elicited cellular immune responses as demonstrated by enzyme-linked immunospot (ELISPOT) assay analyses. In summary, our study indicates that mucosal immunization with rBV SARS-CoV VLPs represent an effective means for eliciting protective systemic and mucosal immune responses against SARS-CoV, providing important information for vaccine design.</p></div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><noCountry><name sortKey="Chen, Jianjun" sort="Chen, Jianjun" uniqKey="Chen J" first="Jianjun" last="Chen">Jianjun Chen</name><name sortKey="Chen, Ze" sort="Chen, Ze" uniqKey="Chen Z" first="Ze" last="Chen">Ze Chen</name><name sortKey="Hu, Qinxue" sort="Hu, Qinxue" uniqKey="Hu Q" first="Qinxue" last="Hu">Qinxue Hu</name><name sortKey="Huang, Li" sort="Huang, Li" uniqKey="Huang L" first="Li" last="Huang">Li Huang</name><name sortKey="Huang, Yi" sort="Huang, Yi" uniqKey="Huang Y" first="Yi" last="Huang">Yi Huang</name><name sortKey="Wang, Hanzhong" sort="Wang, Hanzhong" uniqKey="Wang H" first="Hanzhong" last="Wang">Hanzhong Wang</name><name sortKey="Zheng, Zhenhua" sort="Zheng, Zhenhua" uniqKey="Zheng Z" first="Zhenhua" last="Zheng">Zhenhua Zheng</name></noCountry><country name="République populaire de Chine"><noRegion><name sortKey="Lu, Baojing" sort="Lu, Baojing" uniqKey="Lu B" first="Baojing" last="Lu">Baojing Lu</name></noRegion><name sortKey="Li, Bao" sort="Li, Bao" uniqKey="Li B" first="Bao" last="Li">Bao Li</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002550 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002550 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:2878469
|texte= Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20406307" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |